(iBMDC10-IV group). PBMC obtained at 1.5, 3.5 and ≥18 months post-injection were stimulated using an overlapping 15 per 10 amino acid peptide library covering the rtTA protein and divided in 5 pools (p1 to p5). When PBMC number was limiting, all or some pools were tested together (Mac 6 at 5 1.5 months pi and Mac 7 at 3.5 months pi). Negative controls consisted in PBMC cultured with either medium alone (non activated cells, NA) or an unrelated peptide pool (C-). Positive control (C+) consisted in PMA/ionomycin activation. IFNγ secretion was measured as spot forming cells (SFC) per 10 6 PBMC. Threshold of positivity (dotted line) consists in SFC>50 spots and 3 times the number of SFC obtained with negative peptide pool control (C-). For positive responses (except those performed in duplicates when cell number was limiting), statistical analysis was performed using a DFR test, *** for P value ≤ 0,001, ** for P value ≤ 0,01, * for P value ≤ 0,05.
Fig. S4: Anti-rtTA IFNγ T cell response is predominantly mediated by CD8 T cells in Mac 4
Secretion of IFNγ by rtTA-stimulated PBMCs (Mac 4, iBMDC10-ID group) was evaluated by
ELIspot. The analysis was realized using the same PBMC sample after either CD4 + or CD8 + magnetic cell depletions.
(a) The efficiency of CD4 + and CD8 + T cell depletions were assessed using flow cytometry after CD3 times the number of SFC obtained with negative peptide pool control (C-). For positive responses, statistical analysis was performed using a DFR test, *** for P value ≤ 0,001, ** for P value ≤ 0,01, * for P value ≤ 0,05. Total, CD8-depleted and CD4-depleted PBMCs from a non-injected mock macaque were assessed in parallel and responses for rtTA were all negative (data not shown). The number of SFC normalized to 10 6 PBMC in non activated (NA), negative control using an unrelated peptide pool (C-), positive control (PMA/ionomycin stimulation, C+) and rtTA-peptide stimulations (pools 1 to 5) are indicated for all the macaques tested in control, iBMDC10-ID and iBMDC10-IV groups.
Positive responses are highlighted in grey.
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SUPPLEMENTARY MATERIALS AND METHODS
Anti-rtTA immunostaining. The detection of rtTA protein in iBMDC10 (Fig. S1 ) was realized by immunohistochemistry using polyclonal anti rtTA antibody (TET01, MoBiTec, final concentration of 2.5 µg/mL) overnight at 4°C, donkey anti-rabbit biotinylated secondary antibody (Jackson Immuno
Research) for 1 hour at room temperature and FITC-conjugated streptavidin (Beckman Coulter) during 1 hour at room temperature. Negative control consisted in rabbit serum (2.5 µg/mL). Cell nucleus were stained with DAPI and slides mounted with Prolong GOLD medium (Invitrogen, Life Technologies). Cells were observed with a confocal microscope (Nikon, Champigny, France).
Follow-up of Epo serum levels. Epo levels (Fig. S2) were measured in serum samples by EnzymeLinked Immunosorbent Assay (ELISA) according to manufacturer instructions (Quantikine IVD, R&D Systems).
Follow-up of TetR-specific immune responses in NHP. For Mac 4 (group iBMDC10-ID), an IFNγ
ELISpot assay was performed with either CD4 or CD8-depleted PBMC fractions (Fig. S4 ) using Special StemSep Rhesus CD4+ or CD8+ Tetramer kits (Stem cell technologies, France). The efficacy of T cell subpopulation depletions was assessed by flow cytometry after CD3, CD4 and CD8 staining.
The kinetic in Fig. S3 was performed using total PBMC. IFNγ ELISpot assays were performed as described in the Materials and Methods section.
For all macaques, IL10 secretion was assessed with frozen PBMC isolated at >18 months postinjection (Fig. S5 ). Cells were stimulated with an overlapping peptide library covering the rtTA sequence (15 per 10 mers, Pepscreen, Sigma) split in 5 peptide pools and used at a final concentration of 10μg/mL for each peptide. Briefly, the method consisted in plating 2x10 5 cells on monkey anti-IL10
antibody (Ucytech, Netherlands) pre-coated MultiScreen®HTS filter plates with polyvinyldiene difluoride membrane (PVDF, Millipore, France). Medium alone and an irrelevant pool of peptides served as negative controls whereas PBMC stimulated with Phorbol-12-myristate-13-acetate (PMA, 10ng/mL, Sigma) and Ionomycin, (250ng/mL, Sigma) served as a positive control. After incubation with a biotinylated anti-IL10 antibody (Ucytech, Netherlands), assay revelation was performed as described for the IFNγ ELISpot assay in the Materials and Methods section. Responses were considered positive if the number of spot-forming colonies (SFC) per million cells were >50 and at least 3-fold higher than the negative control.
For the group of pilot macaques (Fig. S7, panel a) , anti-rtTA antibodies were detected by western-blot The polyA\BGH PCR was done using the following program: initial denaturation 20s at 95°C
followed by 45 cycles of 1sec at 95°C and 20sec at 60°C. The ε-globin PCR was done using the following program: initial denaturation 20s at 95°C followed by 45 cycles of 3sec at 90°C and 30sec at 60°C. For each sample, Ct values were compared with those obtained with plasmid standard dilutions (containing either the polyA\BGH sequence or the ε-globin sequence).
Muscle infiltrates. Hematoxyllin phloxin saffron staining (HPS) was performed as per standard histological protocols using formol-fixed and paraffin-embedded muscle sections obtained either at animal necropsy (iBMDC10-ID and iBMDC10-IV groups) or via a surgical biopsy (control group).
Pictures of the sections (Fig. S8) were acquired using NanoZoomer (HAMAMATSU, Japan).
Acquisitions were analyzed by three independent investigators in a blind manner.
Neutralization Assay. Circulating neutralizing factors against rAAV vector were detected in animal sera (Fig. S9 ) obtained 3 months post-injection and decomplemented 30 minutes at 56°C, using a transduction inhibition assay. HeLa cells were infected with wt Adenovirus serotype 5 (multiplicity of infection MOI= 8) during two hours at 37°C. Nine sera dilutions were prepared in DMEM -2% FCS
